Sanofi-Aventis said it’s going to pay Symbion CP Holdings from Primary Health Care for A$560 million ($545 million). Symbion is the market leader in Australia in selling vitamins and mineral supplements.
Sanofi-Aventis said it’s going to pay Symbion CP Holdings from Primary Health Care for A$560 million ($545 million). Symbion is the market leader in Australia in selling vitamins and mineral supplements.